nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—BMPR1B—BMP Signalling and Regulation—BMP2—degenerative disc disease	0.0739	0.0739	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling by BMP—BMP2—degenerative disc disease	0.0439	0.0439	CbGpPWpGaD
Vandetanib—BMPR1B—BMP receptor signaling—BMP2—degenerative disc disease	0.0271	0.0271	CbGpPWpGaD
Vandetanib—VEGFA—Differentiation Pathway—GDF5—degenerative disc disease	0.0239	0.0239	CbGpPWpGaD
Vandetanib—BLK—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0198	0.0198	CbGpPWpGaD
Vandetanib—FGR—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0197	0.0197	CbGpPWpGaD
Vandetanib—VEGFA—Endochondral Ossification—SOX9—degenerative disc disease	0.0181	0.0181	CbGpPWpGaD
Vandetanib—FMO1—Metapathway biotransformation—CHST3—degenerative disc disease	0.0176	0.0176	CbGpPWpGaD
Vandetanib—EGFR—Gastric Cancer Network 2—COL9A3—degenerative disc disease	0.0166	0.0166	CbGpPWpGaD
Vandetanib—KDR—Integrin cell surface interactions—COL9A3—degenerative disc disease	0.0165	0.0165	CbGpPWpGaD
Vandetanib—EGFR—EGFR Transactivation by Gastrin—MMP3—degenerative disc disease	0.0161	0.0161	CbGpPWpGaD
Vandetanib—YES1—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0159	0.0159	CbGpPWpGaD
Vandetanib—VEGFA—Endochondral Ossification—ADAMTS5—degenerative disc disease	0.0152	0.0152	CbGpPWpGaD
Vandetanib—RET—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.0144	0.0144	CbGpPWpGaD
Vandetanib—VEGFA—Endochondral Ossification—ADAMTS4—degenerative disc disease	0.0129	0.0129	CbGpPWpGaD
Vandetanib—KDR—Integrin cell surface interactions—COL9A2—degenerative disc disease	0.0129	0.0129	CbGpPWpGaD
Vandetanib—FMO3—Metapathway biotransformation—CHST3—degenerative disc disease	0.0126	0.0126	CbGpPWpGaD
Vandetanib—LYN—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0119	0.0119	CbGpPWpGaD
Vandetanib—ERBB3—Heart Development—BMP2—degenerative disc disease	0.0117	0.0117	CbGpPWpGaD
Vandetanib—FYN—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0117	0.0117	CbGpPWpGaD
Vandetanib—IRAK4—AGE/RAGE pathway—MMP13—degenerative disc disease	0.011	0.011	CbGpPWpGaD
Vandetanib—VEGFA—Heart Development—BMP2—degenerative disc disease	0.0107	0.0107	CbGpPWpGaD
Vandetanib—FYN—NCAM signaling for neurite out-growth—COL9A3—degenerative disc disease	0.0103	0.0103	CbGpPWpGaD
Vandetanib—LCK—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.00971	0.00971	CbGpPWpGaD
Vandetanib—SRC—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0086	0.0086	CbGpPWpGaD
Vandetanib—EPHA5—Axon guidance—COL9A3—degenerative disc disease	0.00844	0.00844	CbGpPWpGaD
Vandetanib—ABL2—Axon guidance—COL9A3—degenerative disc disease	0.00844	0.00844	CbGpPWpGaD
Vandetanib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP13—degenerative disc disease	0.00843	0.00843	CbGpPWpGaD
Vandetanib—VEGFA—Endochondral Ossification—MMP13—degenerative disc disease	0.00818	0.00818	CbGpPWpGaD
Vandetanib—EPHA8—Axon guidance—COL9A3—degenerative disc disease	0.00814	0.00814	CbGpPWpGaD
Vandetanib—VEGFA—Oncostatin M Signaling Pathway—MMP13—degenerative disc disease	0.00808	0.00808	CbGpPWpGaD
Vandetanib—FYN—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.00802	0.00802	CbGpPWpGaD
Vandetanib—SRC—NCAM signaling for neurite out-growth—COL9A3—degenerative disc disease	0.00757	0.00757	CbGpPWpGaD
Vandetanib—EPHB6—Axon guidance—COL9A3—degenerative disc disease	0.00757	0.00757	CbGpPWpGaD
Vandetanib—ERBB3—Signaling by PDGF—COL9A3—degenerative disc disease	0.00725	0.00725	CbGpPWpGaD
Vandetanib—EPHA6—Axon guidance—COL9A3—degenerative disc disease	0.00711	0.00711	CbGpPWpGaD
Vandetanib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP13—degenerative disc disease	0.00702	0.00702	CbGpPWpGaD
Vandetanib—EGFR—Spinal Cord Injury—SOX9—degenerative disc disease	0.00681	0.00681	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—GDF5—degenerative disc disease	0.00681	0.00681	CbGpPWpGaD
Vandetanib—EPHA5—Axon guidance—COL9A2—degenerative disc disease	0.00659	0.00659	CbGpPWpGaD
Vandetanib—ABL2—Axon guidance—COL9A2—degenerative disc disease	0.00659	0.00659	CbGpPWpGaD
Vandetanib—RIPK2—p75(NTR)-mediated signaling—MMP3—degenerative disc disease	0.00643	0.00643	CbGpPWpGaD
Vandetanib—EPHA8—Axon guidance—COL9A2—degenerative disc disease	0.00635	0.00635	CbGpPWpGaD
Vandetanib—EPHA5—Developmental Biology—COL9A3—degenerative disc disease	0.00602	0.00602	CbGpPWpGaD
Vandetanib—ABL2—Developmental Biology—COL9A3—degenerative disc disease	0.00602	0.00602	CbGpPWpGaD
Vandetanib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP13—degenerative disc disease	0.00599	0.00599	CbGpPWpGaD
Vandetanib—SRC—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.00591	0.00591	CbGpPWpGaD
Vandetanib—EPHB6—Axon guidance—COL9A2—degenerative disc disease	0.00591	0.00591	CbGpPWpGaD
Vandetanib—EPHA8—Developmental Biology—COL9A3—degenerative disc disease	0.00581	0.00581	CbGpPWpGaD
Vandetanib—ERBB3—Signaling by PDGF—COL9A2—degenerative disc disease	0.00566	0.00566	CbGpPWpGaD
Vandetanib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—degenerative disc disease	0.00564	0.00564	CbGpPWpGaD
Vandetanib—EPHA6—Axon guidance—COL9A2—degenerative disc disease	0.00555	0.00555	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—ADAMTS3—degenerative disc disease	0.00545	0.00545	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—ADAMTS5—degenerative disc disease	0.00545	0.00545	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—COL9A3—degenerative disc disease	0.00545	0.00545	CbGpPWpGaD
Vandetanib—VEGFA—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00541	0.00541	CbGpPWpGaD
Vandetanib—EPHB6—Developmental Biology—COL9A3—degenerative disc disease	0.0054	0.0054	CbGpPWpGaD
Vandetanib—EPHA6—Developmental Biology—COL9A3—degenerative disc disease	0.00508	0.00508	CbGpPWpGaD
Vandetanib—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.00494	0.00494	CbGpPWpGaD
Vandetanib—EGFR—AGE/RAGE pathway—MMP13—degenerative disc disease	0.00489	0.00489	CbGpPWpGaD
Vandetanib—FYN—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.00489	0.00489	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by PDGF—COL9A3—degenerative disc disease	0.00485	0.00485	CbGpPWpGaD
Vandetanib—MAP2K5—BDNF signaling pathway—BMP2—degenerative disc disease	0.00471	0.00471	CbGpPWpGaD
Vandetanib—ABL2—Developmental Biology—COL9A2—degenerative disc disease	0.0047	0.0047	CbGpPWpGaD
Vandetanib—EPHA5—Developmental Biology—COL9A2—degenerative disc disease	0.0047	0.0047	CbGpPWpGaD
Vandetanib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—degenerative disc disease	0.0047	0.0047	CbGpPWpGaD
Vandetanib—FYN—Signaling by PDGF—COL9A3—degenerative disc disease	0.00467	0.00467	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—ADAMTS4—degenerative disc disease	0.00463	0.00463	CbGpPWpGaD
Vandetanib—KDR—Axon guidance—COL9A3—degenerative disc disease	0.00462	0.00462	CbGpPWpGaD
Vandetanib—EPHA8—Developmental Biology—COL9A2—degenerative disc disease	0.00453	0.00453	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—COL9A2—degenerative disc disease	0.00425	0.00425	CbGpPWpGaD
Vandetanib—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.00422	0.00422	CbGpPWpGaD
Vandetanib—SRC—Oncostatin M Signaling Pathway—MMP13—degenerative disc disease	0.00422	0.00422	CbGpPWpGaD
Vandetanib—EPHB6—Developmental Biology—COL9A2—degenerative disc disease	0.00422	0.00422	CbGpPWpGaD
Vandetanib—SRC—AGE/RAGE pathway—MMP13—degenerative disc disease	0.00417	0.00417	CbGpPWpGaD
Vandetanib—VEGFA—Axon guidance—COL9A3—degenerative disc disease	0.00415	0.00415	CbGpPWpGaD
Vandetanib—EGFR—Signaling by PDGF—COL9A3—degenerative disc disease	0.00404	0.00404	CbGpPWpGaD
Vandetanib—YES1—Axon guidance—COL9A3—degenerative disc disease	0.00401	0.00401	CbGpPWpGaD
Vandetanib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—degenerative disc disease	0.00401	0.00401	CbGpPWpGaD
Vandetanib—EPHA6—Developmental Biology—COL9A2—degenerative disc disease	0.00396	0.00396	CbGpPWpGaD
Vandetanib—LCK—Signaling by PDGF—COL9A3—degenerative disc disease	0.00389	0.00389	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by PDGF—COL9A2—degenerative disc disease	0.00378	0.00378	CbGpPWpGaD
Vandetanib—FYN—Signaling by PDGF—COL9A2—degenerative disc disease	0.00365	0.00365	CbGpPWpGaD
Vandetanib—KDR—Axon guidance—COL9A2—degenerative disc disease	0.00361	0.00361	CbGpPWpGaD
Vandetanib—SRC—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.0036	0.0036	CbGpPWpGaD
Vandetanib—MKNK1—Disease—CHST3—degenerative disc disease	0.00345	0.00345	CbGpPWpGaD
Vandetanib—SRC—Signaling by PDGF—COL9A3—degenerative disc disease	0.00344	0.00344	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—COL9A3—degenerative disc disease	0.0033	0.0033	CbGpPWpGaD
Vandetanib—VEGFA—Axon guidance—COL9A2—degenerative disc disease	0.00324	0.00324	CbGpPWpGaD
Vandetanib—EGFR—Signaling by PDGF—COL9A2—degenerative disc disease	0.00315	0.00315	CbGpPWpGaD
Vandetanib—YES1—Axon guidance—COL9A2—degenerative disc disease	0.00313	0.00313	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—CHST3—degenerative disc disease	0.00305	0.00305	CbGpPWpGaD
Vandetanib—LCK—Signaling by PDGF—COL9A2—degenerative disc disease	0.00304	0.00304	CbGpPWpGaD
Vandetanib—LYN—Axon guidance—COL9A3—degenerative disc disease	0.00299	0.00299	CbGpPWpGaD
Vandetanib—ABL1—Axon guidance—COL9A3—degenerative disc disease	0.00298	0.00298	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—COL9A3—degenerative disc disease	0.00296	0.00296	CbGpPWpGaD
Vandetanib—FYN—Axon guidance—COL9A3—degenerative disc disease	0.00295	0.00295	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—MMP13—degenerative disc disease	0.00293	0.00293	CbGpPWpGaD
Vandetanib—FYN—BDNF signaling pathway—BMP2—degenerative disc disease	0.00293	0.00293	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—COL9A3—degenerative disc disease	0.00286	0.00286	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—BMP2—degenerative disc disease	0.00283	0.00283	CbGpPWpGaD
Vandetanib—SRC—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00283	0.00283	CbGpPWpGaD
Vandetanib—SRC—Senescence and Autophagy in Cancer—BMP2—degenerative disc disease	0.00278	0.00278	CbGpPWpGaD
Vandetanib—SRC—Signaling by PDGF—COL9A2—degenerative disc disease	0.00269	0.00269	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—COL9A3—degenerative disc disease	0.00264	0.00264	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—COL9A2—degenerative disc disease	0.00257	0.00257	CbGpPWpGaD
Vandetanib—EGFR—Axon guidance—COL9A3—degenerative disc disease	0.00255	0.00255	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—COL9A3—degenerative disc disease	0.00242	0.00242	CbGpPWpGaD
Vandetanib—LYN—Axon guidance—COL9A2—degenerative disc disease	0.00234	0.00234	CbGpPWpGaD
Vandetanib—ABL1—Axon guidance—COL9A2—degenerative disc disease	0.00233	0.00233	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—COL9A2—degenerative disc disease	0.00231	0.00231	CbGpPWpGaD
Vandetanib—FYN—Axon guidance—COL9A2—degenerative disc disease	0.0023	0.0023	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—COL9A2—degenerative disc disease	0.00224	0.00224	CbGpPWpGaD
Vandetanib—MKNK1—Disease—RPL34—degenerative disc disease	0.00222	0.00222	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—COL9A3—degenerative disc disease	0.00221	0.00221	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—CHST3—degenerative disc disease	0.00218	0.00218	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—COL9A3—degenerative disc disease	0.00217	0.00217	CbGpPWpGaD
Vandetanib—SRC—BDNF signaling pathway—BMP2—degenerative disc disease	0.00216	0.00216	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—COL9A3—degenerative disc disease	0.00214	0.00214	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—COL9A3—degenerative disc disease	0.00213	0.00213	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—COL9A3—degenerative disc disease	0.0021	0.0021	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—COL9A2—degenerative disc disease	0.00206	0.00206	CbGpPWpGaD
Vandetanib—ERBB3—Disease—CHST3—degenerative disc disease	0.00204	0.00204	CbGpPWpGaD
Vandetanib—EGFR—Axon guidance—COL9A2—degenerative disc disease	0.00199	0.00199	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—MMP3—degenerative disc disease	0.00196	0.00196	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—PARK2—degenerative disc disease	0.0019	0.0019	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—COL9A2—degenerative disc disease	0.00189	0.00189	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—COL9A3—degenerative disc disease	0.00183	0.00183	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—PARK2—degenerative disc disease	0.00183	0.00183	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—COL9A3—degenerative disc disease	0.00182	0.00182	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—COL9A2—degenerative disc disease	0.00173	0.00173	CbGpPWpGaD
Vandetanib—CYP3A4—Metapathway biotransformation—CHST3—degenerative disc disease	0.00171	0.00171	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—COL9A2—degenerative disc disease	0.0017	0.0017	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—PARK2—degenerative disc disease	0.00168	0.00168	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—COL9A2—degenerative disc disease	0.00167	0.00167	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—COL9A2—degenerative disc disease	0.00166	0.00166	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—COL9A2—degenerative disc disease	0.00164	0.00164	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—COL9A3—degenerative disc disease	0.00155	0.00155	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—PARK2—degenerative disc disease	0.00147	0.00147	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—COL9A2—degenerative disc disease	0.00143	0.00143	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—COL9A2—degenerative disc disease	0.00142	0.00142	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—BMP2—degenerative disc disease	0.00137	0.00137	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CHST3—degenerative disc disease	0.00137	0.00137	CbGpPWpGaD
Vandetanib—ERBB3—Disease—RPL34—degenerative disc disease	0.00132	0.00132	CbGpPWpGaD
Vandetanib—FYN—Disease—CHST3—degenerative disc disease	0.00132	0.00132	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—PARK2—degenerative disc disease	0.00128	0.00128	CbGpPWpGaD
Vandetanib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—degenerative disc disease	0.00127	0.00127	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—BMP2—degenerative disc disease	0.00126	0.00126	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—COL9A3—degenerative disc disease	0.00123	0.00123	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—COL9A2—degenerative disc disease	0.00121	0.00121	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CHST3—degenerative disc disease	0.00121	0.00121	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—PARK2—degenerative disc disease	0.00115	0.00115	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—BMP2—degenerative disc disease	0.00115	0.00115	CbGpPWpGaD
Vandetanib—EGFR—Disease—CHST3—degenerative disc disease	0.00114	0.00114	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—COL9A3—degenerative disc disease	0.00113	0.00113	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—PARK2—degenerative disc disease	0.00112	0.00112	CbGpPWpGaD
Vandetanib—BLK—Immune System—PARK2—degenerative disc disease	0.00111	0.00111	CbGpPWpGaD
Vandetanib—FGR—Immune System—PARK2—degenerative disc disease	0.00111	0.00111	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—PARK2—degenerative disc disease	0.0011	0.0011	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—COL9A3—degenerative disc disease	0.0011	0.0011	CbGpPWpGaD
Vandetanib—LCK—Disease—CHST3—degenerative disc disease	0.0011	0.0011	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—COL9A3—degenerative disc disease	0.00109	0.00109	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—PARK2—degenerative disc disease	0.00108	0.00108	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—PARK2—degenerative disc disease	0.00102	0.00102	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—CHST3—degenerative disc disease	0.00101	0.00101	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—COL9A3—degenerative disc disease	0.000986	0.000986	CbGpPWpGaD
Vandetanib—SRC—Disease—CHST3—degenerative disc disease	0.000971	0.000971	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—COL9A2—degenerative disc disease	0.000961	0.000961	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—COL9A3—degenerative disc disease	0.000952	0.000952	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—BMP2—degenerative disc disease	0.000951	0.000951	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—MMP3—degenerative disc disease	0.000951	0.000951	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—PARK2—degenerative disc disease	0.000933	0.000933	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—PARK2—degenerative disc disease	0.000899	0.000899	CbGpPWpGaD
Vandetanib—YES1—Immune System—PARK2—degenerative disc disease	0.000893	0.000893	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—CHST3—degenerative disc disease	0.00089	0.00089	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—RPL34—degenerative disc disease	0.000881	0.000881	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—COL9A2—degenerative disc disease	0.000879	0.000879	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—MMP3—degenerative disc disease	0.00087	0.00087	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—COL9A2—degenerative disc disease	0.000856	0.000856	CbGpPWpGaD
Vandetanib—FYN—Disease—RPL34—degenerative disc disease	0.000849	0.000849	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—COL9A2—degenerative disc disease	0.000847	0.000847	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—PARK2—degenerative disc disease	0.000796	0.000796	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—MMP3—degenerative disc disease	0.000796	0.000796	CbGpPWpGaD
Vandetanib—ABCC1—Disease—RPL34—degenerative disc disease	0.000778	0.000778	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—COL9A2—degenerative disc disease	0.00077	0.00077	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—COL9A2—degenerative disc disease	0.000744	0.000744	CbGpPWpGaD
Vandetanib—EGFR—Disease—RPL34—degenerative disc disease	0.000733	0.000733	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—COL9A3—degenerative disc disease	0.000725	0.000725	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—COL9A3—degenerative disc disease	0.00071	0.00071	CbGpPWpGaD
Vandetanib—LCK—Disease—RPL34—degenerative disc disease	0.000707	0.000707	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—COL9A3—degenerative disc disease	0.000699	0.000699	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PARK2—degenerative disc disease	0.00068	0.00068	CbGpPWpGaD
Vandetanib—LYN—Immune System—PARK2—degenerative disc disease	0.000666	0.000666	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PARK2—degenerative disc disease	0.000662	0.000662	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—MMP3—degenerative disc disease	0.000659	0.000659	CbGpPWpGaD
Vandetanib—FYN—Immune System—PARK2—degenerative disc disease	0.000655	0.000655	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—BMP2—degenerative disc disease	0.000639	0.000639	CbGpPWpGaD
Vandetanib—SRC—Disease—RPL34—degenerative disc disease	0.000626	0.000626	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—COL9A3—degenerative disc disease	0.000604	0.000604	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—BMP2—degenerative disc disease	0.000585	0.000585	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—COL9A3—degenerative disc disease	0.000582	0.000582	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—BMP2—degenerative disc disease	0.00057	0.00057	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—COL9A2—degenerative disc disease	0.000566	0.000566	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PARK2—degenerative disc disease	0.000566	0.000566	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—BMP2—degenerative disc disease	0.000564	0.000564	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—COL9A2—degenerative disc disease	0.000554	0.000554	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CHST3—degenerative disc disease	0.000549	0.000549	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—COL9A2—degenerative disc disease	0.000546	0.000546	CbGpPWpGaD
Vandetanib—LCK—Immune System—PARK2—degenerative disc disease	0.000545	0.000545	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—COL9A3—degenerative disc disease	0.000515	0.000515	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—BMP2—degenerative disc disease	0.000512	0.000512	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—BMP2—degenerative disc disease	0.000495	0.000495	CbGpPWpGaD
Vandetanib—SRC—Immune System—PARK2—degenerative disc disease	0.000483	0.000483	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—COL9A2—degenerative disc disease	0.000472	0.000472	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—COL9A2—degenerative disc disease	0.000454	0.000454	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MMP3—degenerative disc disease	0.000443	0.000443	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MMP3—degenerative disc disease	0.000405	0.000405	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—COL9A2—degenerative disc disease	0.000402	0.000402	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MMP3—degenerative disc disease	0.000395	0.000395	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP3—degenerative disc disease	0.000391	0.000391	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—BMP2—degenerative disc disease	0.000377	0.000377	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—BMP2—degenerative disc disease	0.000369	0.000369	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—MMP3—degenerative disc disease	0.000368	0.000368	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—BMP2—degenerative disc disease	0.000363	0.000363	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP3—degenerative disc disease	0.000355	0.000355	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP3—degenerative disc disease	0.000343	0.000343	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—BMP2—degenerative disc disease	0.000314	0.000314	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—BMP2—degenerative disc disease	0.000302	0.000302	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CHST3—degenerative disc disease	0.000296	0.000296	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—BMP2—degenerative disc disease	0.000268	0.000268	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP3—degenerative disc disease	0.000261	0.000261	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP3—degenerative disc disease	0.000256	0.000256	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP3—degenerative disc disease	0.000252	0.000252	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP3—degenerative disc disease	0.000217	0.000217	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP3—degenerative disc disease	0.00021	0.00021	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP3—degenerative disc disease	0.000186	0.000186	CbGpPWpGaD
